PATENT CLAIM ANALYSIS

Application Number: 16060864
Application Type: Utility
Filing Date: 2018-06
Publication Date: 2019-01
Patent Classification: ["549", "400000"]

Abstract:
Disclosed is a configurational stereoisomer, referred to as enantiomer E 4 , of flocoumafen, the enantiomer E 4  having, as determined by the chromatographic analysis of flocoumafen including four configurational stereoisomers of flocoumafen, carried out under conditions described hereinafter, a retention time t 4  with a value such that t 1 <t 2 <t 3 <t 4 ; t 1 , t 2  and t 3  representing the retention times of the configurational stereoisomers of flocoumafen different from the enantiomer E 4 , the analysis being carried out at a temperature of 23.5° C.

Claim (Index 24):
Composition according to  claim 14 , comprising an amount of said enantiomer E 4  such that the ratio of this amount to the amount of flocoumafen in the composition is greater than 25%.

Metadata:
- Claim Count in Document: 59.0
- Percentile: 94.0
- Lexical Diversity: 1.98077
- Patent Class: 549.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['16061115', '16061084', '15735677', '15318123', '15318195']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7256736385671761
- 35 USC 102 Novelty (BERT): 0.6422099460846403
- Combined Prediction Score: 0.7173272693189225
- Mean Citation Score: 426.49309000000005
- Max Citation Score: 637.1458
- Similarity Product: 552.9952546901941

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test